Clinical Trial Update: Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating efgartigimod for treatment of myasthenia gravis exacerbations or crisis and is currently recruiting at the University of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• VYVGART (EFGARTIGIMOD ALFA)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Myasthenia Gravis Crisis, Myasthenia Gravis Exacerbations | Phase 4 | Status: RECRUITING